I think you answered your own question @silu73
"Results showed the ADAPT® treated tissue – used in the DurAVR™ 3D single-piece aortic valve –had approximately 38% less calcium concentration compared with the Medtronic AOA™ porcine arm – the tissue used in commercially available TAVR Valves – and 26% less calcium in the bovine arm. Bovine tissue is used in some of the Medtronic SAVR (surgical aortic valve replacement) valves.
The results correlated with existing clinical data and those of the prior head-to-head study with a similar protocol which produced significant differentials between ADAPT® tissue and Edwards Life Sciences’ Thermafix™ tissue at the eight to 12-month mark. "
This is a "gamechanger" - any data which beats multi billion dollar companies as they have is a very exciting result
Excellent results Shareholders and this is a huge step in gaining credibility for ADAPT
Step by Step...
- Forums
- ASX - By Stock
- AVR
- Ann: Anti-Calcification Study
Ann: Anti-Calcification Study, page-7
-
-
- There are more pages in this discussion • 101 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$15.30 |
Change
-0.380(2.42%) |
Mkt cap ! $323.4M |
Open | High | Low | Value | Volume |
$15.70 | $15.94 | $15.02 | $290.0K | 18.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 280 | $15.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.57 | 779 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 280 | 15.100 |
2 | 96 | 15.020 |
1 | 15 | 15.010 |
2 | 582 | 15.000 |
1 | 1000 | 14.850 |
Price($) | Vol. | No. |
---|---|---|
15.570 | 779 | 1 |
15.930 | 250 | 1 |
15.940 | 554 | 1 |
15.950 | 848 | 2 |
16.000 | 1250 | 2 |
Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |